We are live on ! Find out more
FC

Fairpointe Capital Portfolio holdings

AUM $66.3M
1-Year Est. Return 101.32%
This Fund
S&P 500
This Quarter Est. Return
+7.46%
1 Year Est. Return
+101.32%
3 Year Est. Return
+48.06%
5 Year Est. Return
+95.29%
10 Year Est. Return
–
AUM
$5.95B
AUM Growth
+$968M
Cap. Flow
+$572M
Cap. Flow %
9.61%
Top 10 Hldgs %
31.15%
Holding
77
New
5
Increased
36
Reduced
29
Closed
2

Top Buys

Rank Stock Value
1
XYL icon
Xylem
XYL
+$166M
2
AGCO icon
AGCO
AGCO
+$114M
3
RJF icon
Raymond James Financial
RJF
+$105M
4
CTXS
Citrix Systems Inc
CTXS
+$93.7M
5
WOLF icon
Wolfspeed
WOLF
+$49.2M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$93.9M
2
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
+$31.8M
3
LXK
Lexmark Intl Inc
LXK
+$23.1M
4
BLC
BELO CORP SER A
BLC
+$22.8M
5
CGG
CGG
CGG
+$18.6M

Sector Composition

Rank Sector Weight
1 Technology 28.24%
2 Industrials 17.22%
3 Healthcare 10.92%
4 Communication Services 10.04%
5 Financials 7.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DLB icon
51
Dolby
DLB
$4.97B
$27.3M 0.46%
790,100
+114,000
+17% +$3.79M
SF
52
Stifel
SF
$12.4B
$25.6M 0.43%
1,395,900
+307,350
+28% +$5.37M
EW icon
53
Edwards Lifesciences
EW
$49.4B
$21.6M 0.36%
+1,865,400
New +$21.8M
CGG
54
DELISTED
CGG
CGG
$9.59M 0.16%
13,005
-23,730
-65% -$18.6M
FNSR
55
DELISTED
Finisar Corp
FNSR
$2.43M 0.04%
107,200
-41,500
-28% -$855K
SXT icon
56
Sensient Technologies
SXT
$5.22B
$1.57M 0.03%
32,730
+30
+0.1% +$1.31K
LM
57
DELISTED
Legg Mason, Inc.
LM
$993K 0.02%
29,700
+2,100
+8% +$70.3K
TW
58
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
$958K 0.02%
8,955
-2,445
-21% -$215K
HPQ icon
59
HP
HPQ
$26B
$856K 0.01%
89,842
-220
-0.2% -$2.43K
PEP icon
60
PepsiCo
PEP
$196B
$855K 0.01%
10,750
+3,750
+54% +$308K
WOOF
61
DELISTED
VCA Inc.
WOOF
$816K 0.01%
29,700
+1,300
+5% +$36.4K
CCL icon
62
Carnival Corporation Ltd
CCL
$38.1B
$808K 0.01%
24,750
+5,800
+31% +$211K
AVP
63
DELISTED
Avon Products, Inc.
AVP
$803K 0.01%
39,000
+9,900
+34% +$212K
CVE icon
64
Cenovus Energy
CVE
$54.2B
$752K 0.01%
25,200
+2,600
+12% +$76.9K
APA icon
65
APA Corp
APA
$13B
$751K 0.01%
8,820
+850
+11% +$70.6K
QVCGA
66
DELISTED
QVC Group Inc Series A
QVCGA
$622K 0.01%
645
+56
+10% +$54.4K
UL icon
67
Unilever
UL
$142B
$586K 0.01%
13,511
+1,511
+13% +$68.5K
JPM icon
68
JPMorgan Chase
JPM
$916B
$305K 0.01%
5,899
– –
IBM icon
69
IBM
IBM
$213B
$304K 0.01%
1,716
– –
TU icon
70
Telus
TU
$17.4B
$248K ﹤0.01%
15,000
– –
NVS icon
71
Novartis
NVS
$302B
$245K ﹤0.01%
3,571
-391
-10% -$25.9K
DISCK
72
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$204K ﹤0.01%
5,220
-1,600
-23% -$59.2K
DNR
73
DELISTED
Denbury Resources, Inc.
DNR
– –
-898,685
Closed -$15.6M
CBI
74
DELISTED
Chicago Bridge & Iron Nv
CBI
– –
-39,680
Closed -$2.37M
1 2
3

Similar funds

EFM
Ennismore Fund Management London, United Kingdom $71.7M AUM 92.16% 1-Year Est. Return
NI
Northwood Investors Denver, Colorado $73.8M AUM
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
WSC
White Square Capital London, United Kingdom $14.7M AUM 151.72% 1-Year Est. Return
AGEC
Ark Global Emerging Companies Salt Lake City, Utah $14M AUM
CIA
CSat Investment Advisory Detroit, Michigan $119M AUM 77.51% 1-Year Est. Return
FLSMF
Fundsmith Long/Short Master Fund Grand Cayman, Cayman Islands $121M AUM
OHS
Odey Holdings (Switzerland) Zurich, Switzerland, Switzerland $11.1M AUM 64.12% 1-Year Est. Return

Fairpointe Capital's Q3 2013 Portfolio in Review

As of Q3 2013, Fairpointe Capital held 77 positions worth $5.95B, up 19% from $4.98B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Fairpointe Capital deployed $572M of net new capital in Q3 2013, opening 5 new positions and adding to 36 existing holdings. Its largest new stake was Xylem: 6,216,702 shares worth $174M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Boston Scientific, an estimated $93.9M trimmed.

  • Fairpointe Capital's largest Q3 2013 buy was Xylem: 6,216,702 shares worth $174M.
  • Fairpointe Capital added most to Wolfspeed in Q3 2013, an estimated $49.2M increase.
  • Fairpointe Capital's biggest Q3 2013 reduction was Boston Scientific, cutting an estimated $93.9M.
  • Fairpointe Capital fully exited Denbury Resources, Inc. in Q3 2013, selling an estimated $15.6M.
  • Fairpointe Capital's ten largest holdings make up 31% of its $5.95B portfolio in Q3 2013.
  • Fairpointe Capital opened 5 new positions and closed 2 in Q3 2013.
  • Fairpointe Capital's portfolio value rose 19% quarter-over-quarter to $5.95B.

Based on Fairpointe Capital's 13F filing for Q3 2013, filed 12 Nov 2013.